Tesla (NASDAQ:TSLA) plans to manufacture 5,000 units of its Optimus humanoid robot this year, CEO Elon Musk revealed during a recent all-hands meeting. Despite Tesla shares plunging 41.5% year-to-date, Musk encouraged employees to hold their stock, promising a bright and innovative future for the company.
The EV maker aims to begin pilot production of Optimus in 2025, utilizing its full self-driving (FSD) technology to fast-track development. Optimus, capable of walking and handling basic tasks, has evolved into what Musk described as "the most sophisticated humanoid robot on Earth." He claimed Tesla is the only company capable of mass-producing intelligent humanoid robots.
Musk disclosed that Tesla has enough parts to build 10,000 to 12,000 units this year but will focus on a 5,000-unit target in 2024 due to the early-stage nature of the product. The goal is to scale production to 50,000 robots by 2025. Optimus is also expected to begin functioning beyond controlled environments in the latter half of 2025, initially available to Tesla employees.
This push into robotics comes as Tesla faces slowing EV demand, intensifying competition from China’s BYD (SZ:002594), and investor concerns over Musk’s political involvement. However, Musk remains bullish on Tesla’s long-term growth.
The announcement arrives amid a broader industry trend, with tech giants like Apple (NASDAQ:AAPL), Meta (NASDAQ:META), Huawei, and Tencent (HK:0700) preparing to unveil their own humanoid robots in 2024.
Tesla’s entry into the advanced robotics space signals a new frontier, potentially diversifying revenue streams beyond electric vehicles while positioning the company at the forefront of AI-driven innovation.


Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Instagram Outage Disrupts Thousands of U.S. Users 



